OPK Stock - OPKO Health Inc.

OPK Stock Chart

OPK Profile

Opko Health Inc (OPK) is a healthcare company focused on diagnostics and pharmaceuticals. The company operates through two segments: diagnostics and pharmaceuticals. The diagnostics segment is involved in developing and commercializing products and services that help healthcare professionals to diagnose and treat conditions. The pharmaceuticals segment is engaged in the research, development, and commercialization of novel therapies for the treatment of serious diseases, including cancer, autoimmune disorders, and genetic disorders.

Opko Health's products and services include the BioReference Laboratories, which offers a range of laboratory testing services to physicians, clinics, hospitals, and employers; the 4Kscore, a blood test that helps to identify men who are at high risk for aggressive prostate cancer; and Rayaldee, a treatment for secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency.

The company was founded in 1991 and is headquartered in Miami, Florida.

OPK Revenue Chart

OPK Earnings

Analyst Ratings